Evolent Health (EVH) reported earnings on Thur 2 Nov 2017 (a/h)

• Headquarters: Virginia
• Founded: 2011
• evolenthealth.com

** charts before earnings **

 

** charts after earnings **

Evolent Health misses by $0.10, beats on revs; guides FY17 revs above consensus 

• Reports Q3 (Sep) loss of $0.18 per share, excluding non-recurring items, $0.10 worse than the Capital IQ Consensus of ($0.08); revenues rose 79.2% year/year to $107.9 mln vs the $104.49 mln Capital IQ Consensus.
• Co issues upside guidance for FY17, sees FY17 revs of $432-434 mln, excluding non-recurring items, vs. $427.39 mln Capital IQ Consensus Estimate.
• For the three months ended December 31, 2017, Adjusted Revenue is expected to be in the range of $110.0 million to $112.0 million and Adjusted EBITDA is expected to be in the range of $3.0 million to $4.0 million. For the full year 2017, we expect Adjusted Revenue to be in the range of $432.0 million to $434.0 million and Adjusted EBITDA to be in the range of $(3.0) million to $(2.0) million.
• Lives on platform of approximately 2.7 million, an increase of 84.7%